(Q43702066)
English
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated ag
scientific article published on 27 June 2013
Statements
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas (English)
Fredrick Hagemeister
Maria Alma Rodriguez
Steven R Deitcher
Anas Younes
Andre Goy
Nam H Dang
Arthur Forman
Peter McLaughlin
Leonard Jeffrey Medeiros
Barbara Pro
Jorge Romaguera
Felipe Samaniego
Jeffrey A Silverman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference